Skip to content
OpenCapital
AI Tools
Earnings
Screener
Charts
Watchlist
Connect your AI
Get started
Toggle navigation menu
S&P Global
SPGI
Concentration Risk %
Concentration Risk % at other companies
Identive
INVE
10.3%
+7.7pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Weis Markets
WMK
100%
0.0pp
RF Industries
RFIL
100%
0.0pp
Segments
By geography
See full
Asia
23%
+4.5%
Europe
23%
0.0%
Rest Of World
5%
-16.7%
Other financials
Income statement
See full
Revenue
$4.1B
+10.4%
Gross profit
$2.9B
+11.9%
Operating income
$1.8B
+16.8%
Net income
$1.2B
+13.5%
EPS (diluted)
$4.12
+17.7%
Balance sheet
See full
Cash & equivalents
$4.1B
+124%
Total debt
$15.6B
+30.0%
Total equity
$31.6B
-5.3%
Total assets
$62.9B
+4.2%
Cash flow
See full
Operating cash flow
$1.4B
-0.4%
CapEx
$27.0M
-37.2%
Free cash flow
$1.0B
+11.0%
Valuation
See full
Market cap
$126.21B
-22.4%
Enterprise value
$134.67B
-21.5%
P/E
25.6×
-13.7×
P/S
8.1×
-3.1×
Profitability
See full
Gross margin
70.5%
+0.9pp
Operating margin
45.4%
+4.2pp
Net margin
31.4%
+3.2pp
FCF margin
35.6%
-3.0pp
Returns & leverage
See full
Return on equity
15.1%
+3.2pp
Debt / equity
0.4×
0.0×
Current ratio
0.7×
-0.2×